dt01
Nucleic acidexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2011 (NCT01469455)
Timeline
Indications
Mechanism of action
- Molecular identity unknownANTISENSE INHIBITOR
Molecular identity unknown antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dt01
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05719896 | Phase 2 | Feb 28, 2023 | Hanoi Medical University |
| NCT01469455 | Phase 1 | Oct 1, 2011 | CHU AMBROISE PARE, DNA Therapeutics, University of Lyon, University of Nice Sophia Antipolis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CHU AMBROISE PARE | Academic/Hospital | 1 | 0 | 1 | 2011 |
| DNA Therapeutics | For profit | 1 | 1 | 1 | 2011 |
| Hanoi Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Lyon | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Nice Sophia Antipolis | Academic/Hospital | 1 | 0 | 1 | 2011 |
5 organizations
Page 1 / 1